1. Pathophysiological classification of chronic rhinosinusitis
- Author
-
James N. Baraniuk and Hilda Maibach
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,Bleeding Time ,Chronic rhinosinusitis ,Comorbidity ,Bioinformatics ,Risk Assessment ,03 medical and health sciences ,Nasal Polyps ,0302 clinical medicine ,Risk Factors ,Chronic fatigue syndrome ,otorhinolaryngologic diseases ,Humans ,Medicine ,Nasal polyps ,Sinusitis ,030223 otorhinolaryngology ,Retrospective Studies ,Rhinitis ,lcsh:RC705-779 ,business.industry ,Extramural ,Research ,Skin test ,lcsh:Diseases of the respiratory system ,Middle Aged ,medicine.disease ,United States ,Pathophysiology ,3. Good health ,030220 oncology & carcinogenesis ,Immunology ,Female ,Differential diagnosis ,business - Abstract
Background Recent consensus statements demonstrate the breadth of the chronic rhinosinusitis (CRS) differential diagnosis. However, the classification and mechanisms of different CRS phenotypes remains problematic. Method Statistical patterns of subjective and objective findings were assessed by retrospective chart review. Results CRS patients were readily divided into those with (50/99) and without (49/99) polyposis. Aspirin sensitivity was limited to 17/50 polyp subjects. They had peripheral blood eosinophilia and small airways obstruction. Allergy skin tests were positive in 71% of the remaining polyp subjects. IgE was Conclusion CRS subjects were retrospectively classified in to 4 categories using the algorithm of (1) polyp vs. nonpolyp disease, (2) aspirin sensitivity in polyposis, and (3) sinus mucosal thickening vs. nasal osteomeatal disease (CT scan extent of disease) for nonpolypoid subjects. We propose that the pathogenic mechanisms responsible for polyposis, aspirin sensitivity, humoral immunodeficiency, glandular hypertrophy, eosinophilia and atopy are primary mechanisms underlying these CRS phenotypes. The influence of microbial disease and other factors remain to be examined in this framework. We predict that future clinical studies and treatment decisions will be more logical when these interactive disease mechanisms are used to stratify CRS patients.
- Published
- 2005